Results 161 to 170 of about 72,133 (284)

A Case of Severe Pre‐Eclampsia Complicated by HELLP Syndrome and Extensive Hepatic Infarction

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Extensive hepatic infarction is a rare but potentially fatal complication of HELLP syndrome and is often difficult to recognize because of nonspecific clinical manifestations. A 34‐year‐old woman developed HELLP syndrome shortly after cesarean delivery for severe pre‐eclampsia, presenting with oliguria, marked thrombocytopenia (50 × 109/L ...
Tiange Xia   +3 more
wiley   +1 more source

β‐Asarone Attenuates Neuroinflammation of Alzheimer's Disease by Activating Autophagy and Suppressing NLRP3 Inflammasome Assembly

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 2, February 2026.
β‐amyloid activates microglia via the TLR/NF‐κB pathway and primes the NLRP3 inflammasome, driving neuroinflammation. β‐asarone counteracts this by activating autophagy, which degrades NLRP3 components and inhibits inflammasome assembly. This reduces IL‐1β maturation, suppresses cytokine release, and alleviates neuronal damage and cognitive deficits in
Zhiwei Xu   +6 more
wiley   +1 more source

Review of the Efficacy and Mechanisms of Traditional Chinese Medicine for Treating Multi-Organ Damage in Wilson’s Disease

open access: yesDrug Design, Development and Therapy
Hong Chen,1,* Xie Wang,1,* Le Tang,2 Yue Pu,1 Ying Ma,1 Hao Ye,1 Juan Zhang1 1Department of Neurology, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, 230031, People’s Republic of China; 2Department of ...
Chen H   +6 more
doaj  

Technical guidelines for non-clinical pharmacological research of traditional Chinese medicine (TCM) formulae. [PDF]

open access: yesChin Med
Li W   +9 more
europepmc   +1 more source

Recent Studies in Traditional Chinese Medicine (TCM)

open access: yesBiomedical Journal of Scientific & Technical Research, 2023
openaire   +1 more source

GPR183‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer

open access: yesClinical and Translational Discovery, Volume 6, Issue 1, February 2026.
Anti‐PD1 treatment and PI3Kγ inhibition had remarkable therapeutic performance on CD4+ Tcm and CD4+ Tn in lung cancer through potential regulation of PI3K pathway with participation of GPR183. Abstract Background As one of commonly used immune checkpoint inhibition therapies, PD1 monoclonal antibodies exhibit a promising cancer immunotherapy approach ...
Ling Ye   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy